BMC Medical Genomics最新文献

筛选
英文 中文
ALPACA: a visual data mining system for subcellular location-specific knowledge mining from multi-omics data in cancer. ALPACA:一个从癌症多组学数据中挖掘亚细胞位置特异性知识的可视化数据挖掘系统。
IF 2.6 4区 医学
BMC Medical Genomics Pub Date : 2026-11-06 DOI: 10.1186/s12920-026-02440-4
Minwoo Pak, Dabin Jeong, Sungjoon Park, Jeonghyeon Gu, Sangseon Lee, Sun Kim
{"title":"ALPACA: a visual data mining system for subcellular location-specific knowledge mining from multi-omics data in cancer.","authors":"Minwoo Pak, Dabin Jeong, Sungjoon Park, Jeonghyeon Gu, Sangseon Lee, Sun Kim","doi":"10.1186/s12920-026-02440-4","DOIUrl":"10.1186/s12920-026-02440-4","url":null,"abstract":"<p><strong>Background: </strong>Compartments such as subcellular organelles provide adequate environments and interacting partners to the constituent proteins so that their dedicated functions can be carried out properly. While mRNA or protein abundance data is commonly used in computational analysis, data mining from a single abundance data often do not provide sufficient information towards diseases like cancer that introduce various perturbations to biological functions. In addition, transcriptomic and proteomic data do not agree to a large degree. Such challenges make it imperative to comparatively analyze data of multiple omics in terms of subcellular locations to better understand the functional dynamics of cancer. In this paper, A Location-wise Proteome/transcriptome Abundance Comparative Analyzer (ALPACA) is introduced, a web-based visual data mining system for subcellular location-specific knowledge mining from multi-omics data.</p><p><strong>Results: </strong>ALPACA calculates location enrichment distributions from cancer abundance data and visually presents these in a pathway-specific manner, helping researchers observe biological function discrepancies. The effectiveness of ALPACA was demonstrated by reproducing known cancer-related genes and pathways across various types of cancers. For example, ALPACA was able to identify overexpression of TP53 and underexpression of DIABLO/Smac in basal-like breast cancer, as well as high discrepancy in Fc gamma R-mediated phagocytosis pathway among gynaecological cancers with an implicated gene GSN.</p><p><strong>Conclusions: </strong>ALPACA compartmentalizes the whole transcriptome and proteome abundance data subcellular location-wise and visually presents the differences of selected cancers using subcellular locations and biological pathways. The filtering and sorting functions of ALPACA add biological pathway context to the data analysis to help identify potential biomarkers. ALPACA is available at https://github.com/mwpak/ALPACA .</p>","PeriodicalId":8915,"journal":{"name":"BMC Medical Genomics","volume":"16 Suppl 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13741401/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149369888","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multimodal genomic testing in prenatal diagnosis: incremental diagnostic contribution of chromosomal microarray and exome sequencing, real-world NIPT confirmation rates and pregnancy outcomes in 120 consecutive amniocenteses from northeastern Türkiye - a retrospective cohort study. 产前诊断中的多模态基因组检测:染色体微阵列和外显子组测序的增量诊断贡献,现实世界NIPT确认率和来自东北地区120例连续羊膜穿刺的妊娠结局-一项回顾性队列研究。
IF 2.6 4区 医学
BMC Medical Genomics Pub Date : 2026-09-29 DOI: 10.1186/s12920-026-02491-7
Çağrı Doğan, Selçuk Atalay, Hakan Timur
{"title":"Multimodal genomic testing in prenatal diagnosis: incremental diagnostic contribution of chromosomal microarray and exome sequencing, real-world NIPT confirmation rates and pregnancy outcomes in 120 consecutive amniocenteses from northeastern Türkiye - a retrospective cohort study.","authors":"Çağrı Doğan, Selçuk Atalay, Hakan Timur","doi":"10.1186/s12920-026-02491-7","DOIUrl":"10.1186/s12920-026-02491-7","url":null,"abstract":"<p><strong>Background: </strong>Most evidence on chromosomal microarray analysis (CMA) and exome sequencing (ES) in prenatal diagnosis comes from high-volume centres. We evaluated the incremental diagnostic contribution of additional testing modalities, non-invasive prenatal testing (NIPT) confirmation rates and pregnancy outcomes at a regional centre in Türkiye.</p><p><strong>Methods: </strong>Retrospective cohort of 120 consecutive amniocenteses (March 2022-June 2025). The pathway was retrospectively observed, not uniformly implemented: the intended first-tier panel (quantitative fluorescent PCR, G-banded chromosome analysis, CMA) was completed in 94 pregnancies (78.3%), CMA in 101 (84.2%); ES (n = 13) and targeted testing (n = 25) were selective. Findings were classified before analysis as fetal disease-causing or incidental/non-diagnostic. Cumulative yields use the whole cohort as denominator.</p><p><strong>Results: </strong>Abnormal findings occurred in 36 of 120 pregnancies (30.0%): 27 (22.5%) disease-causing and 9 (7.5%) incidental/non-diagnostic - 3 heterozygous pathogenic or likely pathogenic variants in autosomal recessive genes (2.5%) and 6 variants of uncertain significance (VUS; 5.0%). Disease-causing yield rose from 16.7% to 22.5%: seven of the 27 diagnoses were first identified by CMA, ES or targeted testing, a cohort-specific contribution, not a diagnostic yield, as these modalities were not applied uniformly. Abnormal ultrasonography was associated with an abnormal genetic finding (31/83 vs. 5/37; unadjusted OR 3.82, 95% CI 1.35-10.82); not significant for disease-causing findings alone. Within this referral stream, confirmation of 14 high-risk NIPT referrals was 6/6 for trisomies 21 and 18, 0/4 for sex chromosome and rare autosomal aneuploidies and 1/4 for copy-number variants; these should not be read as population-level positive predictive values. Outcome, sought only after an abnormal finding, was documented in 30 of 36; 22 were terminated (trisomy 18, 4/4; isolated VUS, 1/6).</p><p><strong>Conclusions: </strong>CMA, ES and targeted testing added diagnoses in a non-uniformly applied pathway (complete first-tier panel in 78.3%). The findings reinforce the importance of diagnostic confirmation of high-risk NIPT results before irreversible clinical decisions, particularly for less common targets, which were frequently not confirmed in this referral series. Termination frequencies varied across diagnostic categories; these descriptive differences should be considered in the context of the underlying fetal phenotype, diagnostic certainty, and parental preferences when counselling is provided.</p>","PeriodicalId":8915,"journal":{"name":"BMC Medical Genomics","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13640350/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149103658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Identification and splicing assessment of a novel homozygous CFAP65 splice-site variant associated with oligozoospermia and complete asthenozoospermia. 与少精症和完全弱精症相关的新型纯合CFAP65剪接位点变异的鉴定和剪接评估。
IF 2.6 4区 医学
BMC Medical Genomics Pub Date : 2026-09-08 DOI: 10.1186/s12920-026-02466-8
Congcong Teng, Xinhua Tang, Lin Li, Yaxian Ma, Yuancun Zhao, Qing Chen, Hong Shi, Jie Zhang
{"title":"Identification and splicing assessment of a novel homozygous CFAP65 splice-site variant associated with oligozoospermia and complete asthenozoospermia.","authors":"Congcong Teng, Xinhua Tang, Lin Li, Yaxian Ma, Yuancun Zhao, Qing Chen, Hong Shi, Jie Zhang","doi":"10.1186/s12920-026-02466-8","DOIUrl":"10.1186/s12920-026-02466-8","url":null,"abstract":"<p><strong>Background: </strong>Pathogenic variants in CFAP65 have been reported in male infertility with sperm motility defects. This study investigated a novel homozygous CFAP65 splice-site variant identified in a consanguineous family in which the proband presented with oligozoospermia and complete asthenozoospermia.</p><p><strong>Methods: </strong>Whole-exome sequencing was performed to identify candidate variants, followed by population- and disease-database annotation. Kinship and runs of homozygosity analyses were used to assess familial relatedness and autozygosity. RNA Splicer prediction and a minigene assay in HEK-293T cells were performed to evaluate the splicing effect of the identified variant.</p><p><strong>Results: </strong>Semen analysis showed a sperm concentration of 8.1 × 10⁶/mL, with total and progressive motility of 0%. Whole-exome sequencing identified a novel homozygous canonical splice-site variant in CFAP65 (NM_194302.4:c.645 + 1G > A), which was classified as pathogenic according to ACMG guidelines. ROH analysis showed increased autosomal homozygosity in the proband (FROH = 7.88%), supporting parental consanguinity. The minigene assay demonstrated complete exon 6 skipping, resulting in a 103-bp transcript deletion and a predicted frameshifted truncated protein p.(Pro182ArgfsTer29).</p><p><strong>Conclusion: </strong>This study expands the CFAP65 mutational spectrum and supports exon 6 skipping-mediated loss of function as the likely pathogenic mechanism. These findings highlight the value of genetic screening and functional splicing assessment in male infertility with sperm motility defects.</p>","PeriodicalId":8915,"journal":{"name":"BMC Medical Genomics","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13670435/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149179270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Amyotrophic lateral sclerosis coexisting with primary sjögren's syndrome: a clinical case series and exploratory transcriptomic analysis. 肌萎缩侧索硬化症并发原发性sjögren综合征:临床病例系列和探索性转录组学分析。
IF 2.6 4区 医学
BMC Medical Genomics Pub Date : 2026-08-18 DOI: 10.1186/s12920-026-02456-w
Yuxue Nie, Jialei Zhang, Zhe Zhang, Jiaxin Zhou, Wen Zhang, Yan Zhao, Mengtao Li, Lin Qiao
{"title":"Amyotrophic lateral sclerosis coexisting with primary sjögren's syndrome: a clinical case series and exploratory transcriptomic analysis.","authors":"Yuxue Nie, Jialei Zhang, Zhe Zhang, Jiaxin Zhou, Wen Zhang, Yan Zhao, Mengtao Li, Lin Qiao","doi":"10.1186/s12920-026-02456-w","DOIUrl":"https://doi.org/10.1186/s12920-026-02456-w","url":null,"abstract":"<p><strong>Background: </strong>Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by motor neuron degeneration, while primary Sjögren's syndrome (pSS) is a systemic autoimmune disease with prominent immune dysregulation. Although immune-related alterations have been implicated in ALS and autoimmune diseases, the clinical coexistence of ALS and pSS remains poorly characterized. We aimed to describe the clinical features of patients with concomitant ALS and pSS and to explore peripheral blood transcriptomic patterns in independent ALS and pSS cohorts.</p><p><strong>Methods: </strong>We retrospectively identified patients with both ALS and pSS through systematic electronic health record screening and multidisciplinary clinical review. Clinical characteristics, disease chronology, treatment exposure, and outcomes were summarized. In parallel, we performed an exploratory transcriptomic analysis using publicly available peripheral blood datasets from independent ALS and pSS cohorts. Differentially expressed genes and overlapping inflammatory signatures were evaluated, with additional sensitivity assessment performed using an independent ALS cohort.</p><p><strong>Results: </strong>Seven patients fulfilling diagnostic criteria for both ALS and pSS were identified. The temporal relationship between the two diseases was heterogeneous, with variable disease onset sequences and clinical trajectories. Immunomodulatory treatments were associated with transient improvement in systemic autoimmune manifestations in some patients, but no conclusions regarding modification of ALS progression could be established. Transcriptomic analyses identified overlapping upregulated genes between ALS and pSS cohorts, enriched in interferon- and NF-κB-related inflammatory signatures. However, these signatures represent commonly observed inflammatory responses across multiple disease contexts and should not be interpreted as evidence of ALS-pSS-specific biological convergence. Sensitivity assessment using an independent ALS cohort demonstrated partial reproducibility of selected non-specific inflammatory signatures across datasets.</p><p><strong>Conclusions: </strong>Taken together, these findings present two independent, exploratory observations: a rare clinical co-occurrence and a non-specific systemic inflammatory signature identified in unrelated public datasets, both requiring sensitivity assessment and serving as hypothesis-generating baselines for future studies.</p>","PeriodicalId":8915,"journal":{"name":"BMC Medical Genomics","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-08-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13760943/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149401518","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical characterization and genotype-phenotype correlations in Chilton-Okur-Chung syndrome. Chilton-Okur-Chung综合征的临床特征和基因型表型相关性。
IF 2.6 4区 医学
BMC Medical Genomics Pub Date : 2026-08-15 DOI: 10.1186/s12920-026-02448-w
Mehmet Bugrahan Duz, Amaia Lasa-Aranzasti, Ana Cazurro-Gutiérrez, Anna Hackett, Anna Maria Cueto-González, Arthur Arenas Périco, Claudia A L Ruivenkamp, David Gómez-Andrés, Ela Curic, Elizabeth Emma Palmer, Elizabeth A Jones, Ermal Aliu, Hermine E Veenstra-Knol, Himanshu Goel, Ivon Cuscó Marti, Jelmer Legebeke, Jolien S Klein Wassink-Ruiter, Lisa Ewans, Mary Ann Thomas, Marta Codina-Solà, Nicolette S den Hollander, Núria Martínez-Gil, Ryan Gates, Sajel Lala Kana, Shane McKee, Siddharth Banka, Susan Sell, Wendy K Chung
{"title":"Clinical characterization and genotype-phenotype correlations in Chilton-Okur-Chung syndrome.","authors":"Mehmet Bugrahan Duz, Amaia Lasa-Aranzasti, Ana Cazurro-Gutiérrez, Anna Hackett, Anna Maria Cueto-González, Arthur Arenas Périco, Claudia A L Ruivenkamp, David Gómez-Andrés, Ela Curic, Elizabeth Emma Palmer, Elizabeth A Jones, Ermal Aliu, Hermine E Veenstra-Knol, Himanshu Goel, Ivon Cuscó Marti, Jelmer Legebeke, Jolien S Klein Wassink-Ruiter, Lisa Ewans, Mary Ann Thomas, Marta Codina-Solà, Nicolette S den Hollander, Núria Martínez-Gil, Ryan Gates, Sajel Lala Kana, Shane McKee, Siddharth Banka, Susan Sell, Wendy K Chung","doi":"10.1186/s12920-026-02448-w","DOIUrl":"10.1186/s12920-026-02448-w","url":null,"abstract":"<p><strong>Background: </strong>Chilton-Okur-Chung neurodevelopmental syndrome is a rare disorder characterized by global developmental delay, variable intellectual disability, behavioral challenges, and structural brain anomalies caused by variants in CDC42BPB. CDC42BPB encodes MRCKβ, a ubiquitously expressed serine/threonine kinase involved in cytoskeletal regulation. The phenotypic spectrum and genotype-phenotype relationships remain incompletely characterized.</p><p><strong>Methods: </strong>We aggregated data from 20 newly identified individuals and 17 previously reported individuals. We analyzed the data for genotype-phenotype correlations according to variant type.</p><p><strong>Results: </strong>Developmental delay was the most common phenotype, affecting 85% of individuals, with early delays notable in walking and speech. Intellectual disability was observed in 62%. Behavioral diagnoses included autism spectrum disorder (68%) and ADHD (60%). Structural brain abnormalities were present in 48% of cases, predominantly affecting the cerebellum and ventricles. Dysmorphic features were present in 83% of cases. Hypotonia was present in 68%, seizures in 41%, and macrocephaly in 38%. Genotype-phenotype analysis indicated that predicted loss-of-function (LoF) variants were generally associated with milder neurodevelopmental features than missense variants. A male predominance was observed despite this being an autosomal dominant condition, suggesting a possible protective effect in females. Some heterozygous predicted LoF variants were inherited from self-reported unaffected parents or with subtle neurodevelopmental or cardiac features, supporting incomplete penetrance and variable expressivity.</p><p><strong>Conclusions: </strong>Our findings highlight the differences between predicted loss-of-function and missense variants. Future studies assessing biochemical differences in kinase activity and substrate specificity may explain these clinical differences.</p>","PeriodicalId":8915,"journal":{"name":"BMC Medical Genomics","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-08-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13753119/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149392706","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vitamin D binding protein gene polymorphisms and the risk of respiratory diseases: a meta-analysis and systematic review. 维生素D结合蛋白基因多态性与呼吸系统疾病的风险:荟萃分析和系统综述。
IF 2.6 4区 医学
BMC Medical Genomics Pub Date : 2026-08-13 DOI: 10.1186/s12920-026-02443-1
Jing Zhang, Hongwen Li, Xiangyu Chi, Guoying Zhang, Hongjuan Jiang
{"title":"Vitamin D binding protein gene polymorphisms and the risk of respiratory diseases: a meta-analysis and systematic review.","authors":"Jing Zhang, Hongwen Li, Xiangyu Chi, Guoying Zhang, Hongjuan Jiang","doi":"10.1186/s12920-026-02443-1","DOIUrl":"https://doi.org/10.1186/s12920-026-02443-1","url":null,"abstract":"&lt;p&gt;&lt;strong&gt;Background: &lt;/strong&gt;Recent studies have found that VDBP gene polymorphism is closely related to the pathogenesis of some respiratory diseases. Rs7041 and rs4588 are two major single-nucleotide polymorphisms(SNPs) in the GC gene encoding VDBP. Different combinations of these variants give rise to three major haplotypic isoforms, GC*1F, GC*1S, and GC*2, which may influence pulmonary immune-inflammatory responses and immune regulation. This systematic review and meta-analysis aimed to clarify the associations between VDBP gene polymorphisms and respiratory diseases including chronic obstructive pulmonary disease(COPD), asthma, Corona Virus Disease-2019(COVID-19) and tuberculosis, so as to provide evidence for the formulation of individualized prevention and therapeutic strategies in the future.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Methods: &lt;/strong&gt;We searched the Pubmed, web of science, Wanfang, Embase and China National Knowledge Infrastructure(CNKI) to find the eligible case-control studies. Study quality was assessed using the Newcastle-Ottawa Scale (NOS). Forest plots were generated using Review Manager version 5.4, and pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Results: &lt;/strong&gt;A total of 30 studies involving 8,844 participants were included. No significant associations were observed between the rs7041 or rs4588 polymorphism and COPD susceptibility (both P &gt; 0.05). In the analysis of GC variants, GC*1F-related genetic models were associated with an increased risk of COPD. The ORs for GC*1F/1F versus GC*1F/1S and for GC*1F/1F versus GC*1S/1S group were 1.73 and 2.17, respectively. The OR for the GC*1F/1F homozygous comparison was 1.96, and the GC*1F allele analysis was also statistically significant (P = 0.0003). Ethnicity-based subgroup analyses suggested that GC*1F may be primarily associated with increased COPD susceptibility in East Asian populations. In non-East Asian populations, GC*2 showed a trend toward a reduced risk of COPD, although this association did not reach statistical significance (OR = 0.52, P = 0.09). In the asthma analysis, GC*2 may be associated with an increased risk of asthma (P ≤ 0.001). However, because relatively few studies were available for asthma, COVID-19, and tuberculosis, and substantial heterogeneity was present in some analyses, the current evidence remains insufficient to draw definitive conclusions regarding the associations between GC variants and these diseases.&lt;/p&gt;&lt;p&gt;&lt;strong&gt;Conclusion: &lt;/strong&gt;The GC*1F allele and GC*1F/1F diplotype may be associated with increased susceptibility to COPD, particularly in East Asian populations, whereas no significant associations were observed between rs7041 or rs4588 and COPD risk. GC*2 may show a potentially protective trend against COPD in non-East Asian populations but may be associated with increased asthma susceptibility. Given the limited and highly heterogeneous evidence regarding asthma, COVID-19, and tuberculosis, furth","PeriodicalId":8915,"journal":{"name":"BMC Medical Genomics","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-08-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13757158/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149401519","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Real-world comparison of genome- and exome-based diagnostic workflows in a pediatric Albanian rare disease cohort. 阿尔巴尼亚儿科罕见病队列中基于基因组和外显子组的诊断工作流程的现实世界比较。
IF 2.6 4区 医学
BMC Medical Genomics Pub Date : 2026-08-11 DOI: 10.1186/s12920-026-02450-2
Paskal Cullufi, Mirela Tabaku, Aliaksandr Skrahin, Sonila Tomori, Virtut Velmishi, Ermira Dervishi, Gladiola Hoxha, Agim Gjikopulli, Erjon Troja, Aferdita Tako, Volha Skrahina, Arndt Rolfs
{"title":"Real-world comparison of genome- and exome-based diagnostic workflows in a pediatric Albanian rare disease cohort.","authors":"Paskal Cullufi, Mirela Tabaku, Aliaksandr Skrahin, Sonila Tomori, Virtut Velmishi, Ermira Dervishi, Gladiola Hoxha, Agim Gjikopulli, Erjon Troja, Aferdita Tako, Volha Skrahina, Arndt Rolfs","doi":"10.1186/s12920-026-02450-2","DOIUrl":"10.1186/s12920-026-02450-2","url":null,"abstract":"<p><strong>Background: </strong>Pediatric rare diseases are clinically and genetically heterogeneous, often resulting in delayed molecular diagnosis. In routine clinical practice, diagnostic outcomes reflect the combined performance of complete workflows that may differ in sample source, sequencing depth, laboratory procedures, bioinformatics, interpretation, and reporting. We compared two independent clinical diagnostic workflows applied in parallel to the same Albanian pediatric cohort.</p><p><strong>Methods: </strong>Seventy-two patients with suspected rare genetic disorders underwent genome sequencing (GS) from saliva or buccal swabs at approximately 30 × mean depth and exome sequencing (ES) from dried blood spots, with more than 98% of target bases covered at ≥20×. The ISO-accredited laboratories independently performed sequencing, analysis, interpretation, and reporting. We assessed report-level primary diagnostic yield, paired outcomes, variant classes, discordant findings, and laboratory-reported secondary/additional findings. Variants of uncertain significance (VUS) were excluded from yield. Raw data were not centrally reanalyzed, and sample types were not cross-tested.</p><p><strong>Results: </strong>At least one workflow reported a pathogenic or likely pathogenic finding interpreted as a primary molecular diagnosis in 29/72 patients (40.3%; 95% CI, 28.9-52.5). GS reports contained primary diagnoses for 26/72 patients (36.1%; 95% CI, 25.1-48.3) and ES reports for 16/72 (22.2%; 95% CI, 13.3-33.6). Primary outcomes were concordant in 56 participants (13 positive and 43 negative) and discordant in 16 (13 GS-only and three ES-only). The GS laboratory also reported 13 secondary/additional variant-level rows in 11 patients (12 P/LP rows and one VUS row), including seven patients without a primary diagnosis.</p><p><strong>Conclusions: </strong>The workflows produced overlapping but non-identical clinical reports, and neither workflow was comprehensive. The observed differences cannot be attributed to sequencing technology alone because sample type, depth, laboratory, bioinformatics, prioritization, and reporting scope were not harmonized. Implementation decisions should integrate diagnostic contribution with cost, turnaround time, infrastructure, workforce, governance, and local feasibility.</p>","PeriodicalId":8915,"journal":{"name":"BMC Medical Genomics","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-08-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13749661/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149377081","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Expression profiles of long non-coding RNAs ROCR, CFLAR-AS1, ST7-AS1, and ST7-AS2 in diffuse large B-cell lymphoma: a case-control study focusing on GCB and non-GCB subtypes. 长链非编码rna ROCR、CFLAR-AS1、ST7-AS1和ST7-AS2在弥漫性大b细胞淋巴瘤中的表达谱:一项针对GCB和非GCB亚型的病例对照研究
IF 2.6 4区 医学
BMC Medical Genomics Pub Date : 2026-08-10 DOI: 10.1186/s12920-026-02452-0
Ali Rajabi, Maryam Ghaffari Laleh, Reza Safaralizadeh, Asma Rajabi, Samaneh Tayefeh-Gholami, Ali Saber
{"title":"Expression profiles of long non-coding RNAs ROCR, CFLAR-AS1, ST7-AS1, and ST7-AS2 in diffuse large B-cell lymphoma: a case-control study focusing on GCB and non-GCB subtypes.","authors":"Ali Rajabi, Maryam Ghaffari Laleh, Reza Safaralizadeh, Asma Rajabi, Samaneh Tayefeh-Gholami, Ali Saber","doi":"10.1186/s12920-026-02452-0","DOIUrl":"10.1186/s12920-026-02452-0","url":null,"abstract":"<p><strong>Background: </strong>Diffuse Large B-cell lymphoma (DLBCL) is subdivided into the Germinal Center B-cell (GCB) and non-Germinal Center B-cell (non-GCB)/Activated B-cell (ABC) subtypes, with significant clinical, phenotypic, and genetic variability. Investigating DLBCL's molecular mechanisms and developing tailored treatment strategies at the molecular level could improve diagnostic precision and treatment outcomes. Advances in sequencing technologies have enabled the identification of numerous lncRNAs with abnormal expression in DLBCL. This study aimed to identify lncRNAs with diagnostic potential in DLBCL using bioinformatics, confirmed through laboratory experiments.</p><p><strong>Method: </strong>The gene expression dataset for GSE207388 was obtained from the Gene Expression Omnibus database. Significance analysis of the RNA sequencing algorithm was used to identify differentially expressed genes (DEGs), followed by GO and KEGG enrichment analyses of co-expressed genes. Lymph node tissue specimens were collected from 261 DLBCL patients and 123 controls at two hospitals in Iran between 2023 and 2024. Quantitative real-time PCR was performed to evaluate gene expression, and ROC curve analysis was conducted to assess the diagnostic potential of the selected lncRNAs.</p><p><strong>Results & conclusion: </strong>The dataset included the expression profiles of 19,305 genes, of which 299 were selected using the cut-off criteria of fold change > 2 and p ≤ 0.001. Based on GO and KEGG enrichment analyses, four key lncRNAs-ROCR, CFLAR-AS1, ST7-AS1, and ST7-AS2-were selected for further analysis. Elevated expression levels of ROCR, CFLAR-AS1, ST7-AS1, and ST7-AS2 were observed when comparing DLBCL versus control groups and non-GCB versus GCB subtypes. Additionally, ROC curve analysis revealed the strong diagnostic potential of these lncRNAs, particularly ST7-AS2. These findings significantly enhance our understanding of the molecular mechanisms underlying DLBCL, potentially leading to more precise therapeutic strategies.</p>","PeriodicalId":8915,"journal":{"name":"BMC Medical Genomics","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13737518/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149340508","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A novel homozygous missense variant in the GAMT gene causing cerebral creatine deficiency syndrome 2 in an Iranian patient: molecular dynamics insights and literature review. 一种新的GAMT基因纯合错义变异导致伊朗患者脑肌酸缺乏综合征2:分子动力学见解和文献综述。
IF 2.6 4区 医学
BMC Medical Genomics Pub Date : 2026-08-10 DOI: 10.1186/s12920-026-02451-1
Ahmed Al-Karim, Teymoor Khosravi, Mohaddese Hajmohammadi, Mohaddese Mohsenipour, Ali Kowsari, Masoud Golalipour, Nader Mansour Samaei, Morteza Oladnabi
{"title":"A novel homozygous missense variant in the GAMT gene causing cerebral creatine deficiency syndrome 2 in an Iranian patient: molecular dynamics insights and literature review.","authors":"Ahmed Al-Karim, Teymoor Khosravi, Mohaddese Hajmohammadi, Mohaddese Mohsenipour, Ali Kowsari, Masoud Golalipour, Nader Mansour Samaei, Morteza Oladnabi","doi":"10.1186/s12920-026-02451-1","DOIUrl":"10.1186/s12920-026-02451-1","url":null,"abstract":"<p><p>Cerebral creatine deficiency syndrome 2 (CCDS2; OMIM #612,736) is a rare autosomal recessive neurometabolic disorder caused by variants in the GAMT gene, leading to deficient creatine synthesis in the brain. Here, we report a 17-year-old Iranian Fars female patient from a consanguineous marriage presenting with severe intellectual disability, inability to walk, muscle atrophy, and epileptiform EEG activity. Whole-exome sequencing identified a previously unreported homozygous missense variant in GAMT (NM_000156.6: c.326A > G, p.Lys109Arg), classified as likely pathogenic according to ACMG guidelines. The affected lysine residue at position 109 is highly conserved across species. Molecular dynamics (MD) simulations over 100 ns revealed that the p.Lys109Arg substitution induces a more compact global conformation (lower RMSD and Rg) but drastically alters the dynamic coupling network. Compared to wild-type, the mutant exhibited a substantially higher standard deviation in the cross-correlation matrix (0.323 vs. 0.236) and a markedly increased number of both strongly positive (4,006 vs. 1,574) and strongly negative (3,326 vs. 576) correlated residue pairs, indicating the emergence of extensive long-range allosteric perturbations that may disrupt functional dynamics and stability. Our report highlights the value of MD simulations as a tool to evaluate the structural consequences of genetic variants.</p>","PeriodicalId":8915,"journal":{"name":"BMC Medical Genomics","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-08-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13746702/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149377080","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevotella stercorea links gut microbiome ecology to respiratory infection protection through host-context-dependent, richness-independent associations. 普雷沃氏菌通过宿主环境依赖、丰度独立的关联将肠道微生物群生态学与呼吸道感染保护联系起来。
IF 2.6 4区 医学
BMC Medical Genomics Pub Date : 2026-08-08 DOI: 10.1186/s12920-026-02449-9
Ogochukwu Ofordile
{"title":"Prevotella stercorea links gut microbiome ecology to respiratory infection protection through host-context-dependent, richness-independent associations.","authors":"Ogochukwu Ofordile","doi":"10.1186/s12920-026-02449-9","DOIUrl":"10.1186/s12920-026-02449-9","url":null,"abstract":"<p><strong>Background: </strong>Using a longitudinal cohort of 633 Gambian children (IHAT-GUT, NCT02941081), we investigated two ecologically distinct pathways potentially linking Prevotella stercorea abundance to infection risk: a community-mediated pathway operating through overall gut microbiome richness, and a species-specific pathway operating independently of it.</p><p><strong>Methods: </strong>We modelled P. stercorea abundance in relation to gut microbiome richness, adverse-event incidence (diarrhoea, acute respiratory infection [ARI], fever), inflammatory biomarkers (CRP, AGP; measured at enrolment [D1] only), and weight-for-age z-score (WAZ), using richness-mediation analysis, negative binomial and joint-species models, and WAZ-stratified interaction models, with Benjamini-Hochberg correction applied within each family of related tests.</p><p><strong>Results: </strong>P. stercorea abundance positively predicted gut microbiome richness, consistent with a role in community-level colonisation resistance for enteric outcomes. Its association with reduced ARI persisted largely unchanged after richness adjustment, consistent with a richness-independent, species-autonomous pathway. WAZ was uncorrelated with microbiome richness within strata, consistent with WAZ serving as a proxy for host immune-metabolic reserve rather than a determinant of microbiome composition. In Low-WAZ children, P. stercorea abundance at Day 1 was associated with suppressed CRP; in High-WAZ children, elevated Day 1 inflammation predicted subsequent P. stercorea abundance at Day 85. ARI and fever protection was richness-independent and concentrated in Low-WAZ children (q≤ 0.006); P. copri did not retain an independent protective association when modelled jointly with P. stercorea (q = 0.381 vs. q = 0.016).</p><p><strong>Conclusions: </strong>These findings are consistent with a richness-independent, host-context-dependent association between P. stercorea abundance and respiratory infection risk. Given the observational design, causal and mechanistic interpretations remain hypothesis-generating; experimental validation and independent replication are needed before translational application can be considered.</p>","PeriodicalId":8915,"journal":{"name":"BMC Medical Genomics","volume":"19 1","pages":""},"PeriodicalIF":2.6,"publicationDate":"2026-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13737801/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149332256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书